More info
Antitumor agent in pancreatic cancer via impairing Ras-MAPK signaling, down-regulating anti-apoptotic protein Bcl-2, and up-regulating mitochondrial apoptosis pathway-related proteins (Bax, cytosolic Cytochrome c and Caspase 3) and cyclin-dependent kinase 2 and Cyclin A, E